Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease

I. Jialal; S. Devaraj

doi:10.1002/cpt.105

Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease

I. Jialal, S. Devaraj

Pathology and Laboratory Medicine

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.

Original language	English (US)
Pages (from-to)	121-123
Number of pages	3
Journal	Clinical Pharmacology and Therapeutics
Volume	98
Issue number	2
DOIs	https://doi.org/10.1002/cpt.105
State	Published - Aug 1 2015

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/cpt.105

Fingerprint Dive into the research topics of 'Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease'. Together they form a unique fingerprint.

Cite this

@article{f06b4d74a6a143cab43ac19b9cb04cb5,

title = "Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease",

abstract = "Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies. ",

author = "I. Jialal and S. Devaraj",

year = "2015",

month = aug,

day = "1",

doi = "10.1002/cpt.105",

language = "English (US)",

volume = "98",

pages = "121--123",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Anti-inflammatory Strategies to Prevent Diabetic Cardiovascular Disease

AU - Jialal, I.

AU - Devaraj, S.

PY - 2015/8/1

Y1 - 2015/8/1

N2 - Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.

AB - Diabetes is a proinflammatory state and inflammation is crucial in the genesis of vascular complications. While there are many anti-inflammatory strategies, most of which have been shown to reduce inflammation in diabetes, there is sparse data on reduction in cardiovascular events (CVEs). To date, the only anti-inflammatory strategies that have been shown to reduce CVE in diabetes include statins, angiotensin receptor blockers, metformin, and pioglitazone. We also discuss the role of novel emerging therapies.

UR - http://www.scopus.com/inward/record.url?scp=84943353350&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943353350&partnerID=8YFLogxK

U2 - 10.1002/cpt.105

DO - 10.1002/cpt.105

M3 - Article

C2 - 25732108

AN - SCOPUS:84943353350

VL - 98

SP - 121

EP - 123

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 2

ER -